About PSCO
The Pakistan Society of Clinical Oncology (PSCO) is the leading national platform representing all professionals involved in cancer treatment. Its growing membership includes clinical oncologists, radiation and medical oncologists, hematologists, nuclear medicine experts, and allied specialists. PSCO promotes collaborative cancer care, supports research and education, and encourages cost-effective treatment models. It strives to enhance national cancer care standards through training, multidisciplinary teamwork, and partnerships with institutions and international oncology organizations.
PSCO AT A GLANCE
Pakistan faces a silent epidemic: 178,000+ new cancer cases emerge annually, yet specialized care remains inaccessible to millions. As the nation’s largest oncology coalition, PSCO unites 2,500+ specialists to bridge this gap through research, advocacy, and standardized treatment protocols.
With treatment outcomes varying 300% between urban and rural areas, our National Cancer Registry (120+ hospitals contributing) exposes critical gaps. This real-time data redirects resources to high-burden regions and shapes policy reforms – accelerating our mission to cut preventable cancer deaths by 40% before 2030.
Pakistan has only 1 cancer specialist per 16,000 patients. Through accredited fellowships and virtual tumor boards, we’re training 450+ next-generation oncologists annually – focusing on geriatric oncology and cost-effective protocols to tackle the 23% surge in age-related cancers.
45% of Pakistan’s cancer burden stems from preventable causes. We prioritize vaccination drives (HPV), anti-tobacco legislation, and public screening camps – targeting root causes before treatment becomes necessary. Our evidence-based approach saves 3x more lives per rupee spent versus late-stage interventions.
